We also found that inhibiting FAK activity via either siRNA-mediated FAK depletion or treatment of cells with the FAK kinase inhibitor PF-573228 [14] effectively inhibited melanoma cell migration but increased the proteolytic activity of metastatic melanoma. Here, PTK2 is linked to metastatic melanoma.